Cue Biopharma (CUE) Net Margin Growth (1y) (2019 - 2025)
Cue Biopharma (CUE) Net Margin Growth (1y) (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,245.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,120.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Cue Biopharma |
581.16 Mn |
553.47 Mn |
- |
-125,419.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
-125,419.00 |
| Sep 30, 2025 |
-8,913.00 |
| Jun 30, 2025 |
8,895.00 |
| Mar 31, 2025 |
-217,593.00 |
| Dec 31, 2024 |
220,836.00 |
| Sep 30, 2024 |
25,647.00 |
| Jun 30, 2024 |
56,270.00 |
| Mar 31, 2024 |
610,723.00 |
| Dec 31, 2023 |
871,661.00 |
| Sep 30, 2023 |
1.56 Mn |
| Jun 30, 2023 |
4.99 Mn |
| Mar 31, 2023 |
-538,680.00 |
| Dec 31, 2022 |
-933,091.00 |
| Sep 30, 2022 |
-1.56 Mn |
| Jun 30, 2022 |
-5.04 Mn |
| Mar 31, 2022 |
-62,028.00 |
| Dec 31, 2021 |
219,689.00 |
| Sep 30, 2021 |
88,235.00 |
| Jun 30, 2021 |
63,244.00 |
| Mar 31, 2021 |
61,901.00 |
